DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study
Year: 2025
Type: article
Language: en
Topic: Acute Myeloid Leukemia Research
Authors and affiliations:
raw_author_name: Carmelo Gurnari
raw_affiliation_strings: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. gurnarc@ccf.org
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. gurnarc@ccf.org
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
raw_author_name: Hideki Makishima
raw_affiliation_strings: Department of Hematology and Medical Oncology, Shinshu University, Matsumoto, Japan
raw_author_name: Arda Durmaz
raw_affiliation_strings: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
raw_author_name: Enrico Attardi
raw_affiliation_strings: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
raw_author_name: Ryunosuke Saiki
raw_affiliation_strings: Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
raw_author_name: Alex Bataller
raw_affiliation_strings: The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Guilherme Sapinho
raw_affiliation_strings: Serviço de Hematologia e Transplantação de Medula, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
The Department of Haematological Medicine, King's College Hospital NHS, London, UK
raw_author_name: Lukasz Gondek
raw_affiliation_strings: Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
raw_author_name: Yasuhito Nannya
raw_affiliation_strings: Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
raw_author_name: Steve Best
raw_affiliation_strings: The Department of Haematological Medicine, King's College Hospital NHS, London, UK
raw_author_name: Pramila Krishnamurthy
raw_affiliation_strings: The Department of Haematological Medicine, King's College Hospital NHS, London, UK
raw_author_name: Kar Lok Kong
raw_affiliation_strings: The Department of Haematological Medicine, King's College Hospital NHS, London, UK
raw_author_name: Yoshiko Atsuta
raw_affiliation_strings: Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
raw_author_name: Senji Kasahara
raw_affiliation_strings: Department of Hematology, Gifu Municipal Hospital, Gifu, Japan
raw_author_name: Kazuma Ohyashiki
raw_affiliation_strings: Department of Hematology, Tokyo Medical University, Tokyo, Japan
raw_author_name: Yasushi Miyazaki
raw_affiliation_strings: Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
raw_author_name: Nobuhiro Kanemura
raw_affiliation_strings: Department of Hematology, Gifu University, Gifu, Japan
raw_author_name: Nobuhiro Hiramoto
raw_affiliation_strings: Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
raw_author_name: Francesco Versino
raw_affiliation_strings: Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
The Department of Haematological Medicine, King's College Hospital NHS, London, UK
raw_author_name: Maria Julia Montoro
raw_affiliation_strings: Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: Sara Torres-Esquius
raw_affiliation_strings: Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: Andres Jerez Cayuela
raw_affiliation_strings: Department of Hematology, Hospital Universitari Vall d'Hebron (HUVH), Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
raw_author_name: Miguel López-Esteban
raw_affiliation_strings: Department of Hematology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
raw_author_name: Carolina Martínez-Laperche
raw_affiliation_strings: Department of Hematology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
raw_author_name: Hussein Awada
raw_affiliation_strings: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
raw_author_name: Valeria Visconte
raw_affiliation_strings: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
raw_author_name: Courtney D. DiNardo
raw_affiliation_strings: The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Maria Teresa Voso
raw_affiliation_strings: Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
raw_author_name: Amy E. DeZern
raw_affiliation_strings: Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
raw_author_name: Guillermo Garcia-Manero
raw_affiliation_strings: The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Austin G. Kulasekararaj
raw_affiliation_strings: The Department of Haematological Medicine, King's College Hospital NHS, London, UK
raw_author_name: Jaroslaw P. Maciejewski
raw_affiliation_strings: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
raw_author_name: Seishi Ogawa
raw_affiliation_strings: Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan. sogawa-tky@umin.ac.jp
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan